Xena Therapies

Xena Therapies manufactures clinically-tested, drug-free cooling and heating therapy products using proprietary phase change material (PCM) technology. Founded in December 2019 and operational since February 2020, the company produces wearable therapeutic devices for pain management, post-surgical recovery, and women's health applications including menopause symptom relief and heat stress mitigation. The product portfolio encompasses three primary brands: ONYX COOL (therapeutic wraps for pain relief and post-surgical recovery), Opal Cool (cooling solutions designed for women across life stages, including motherhood, menopause, and MS management), and WARMMS Therapy (infrared heat therapy for pain management and metabolic enhancement). All products are manufactured in Minnesota and marketed as safer alternatives to traditional ice therapy, eliminating risks of ice burn or frostbite. The 58°F products maintain optimal temperature for approximately one hour; 80°F products for two hours. ONYX COOL products have demonstrated higher patient satisfaction scores and reduced pain medication usage in post-surgical populations. The company holds FDA Class One medical device registration and emphasizes physician recommendation. Products are available through direct e-commerce channels and wholesale distribution. Target markets include healthcare workers, athletes, post-surgical patients, menopausal women, and patients with multiple sclerosis or heat-related conditions.